Supernus Pharmaceuticals Inc. News
Supernus Higher as Pediatric ADHD Drug Is Cleared by FDA
Supernus shares are higher after the Food and Drug Administration cleared the company to market a new ADHD drug for children.
Supernus Up on Report of Progress With ADHD Treatment
Supernus said that a Phase 3 trial 'met the primary endpoint ... compared to placebo in improving the symptoms of ADHD.'
Biogen, UnitedHealth: 5 Top Stock Gainers for Wednesday
Super Micro Computer, Biogen, Neurocrine Biosciences, Supernus Pharmaceuticals and UnitedHealth.
CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round
Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.
Victory Comes From Leadership: Cramer's 'Mad Money' Recap
Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.
MediWound Shares Lower After Pricing Stock Offering - Biotech Movers
MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.
UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round
Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.
Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)
Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.
Fed Inflation Gauge Slowed Again in October, Supporting Dovish Powell
Further slowing in the Fed's preferred inflation gauge is adding heft to Chairman Jerome Powell's signals of smaller rate hikes.
Costco Stock Slides On Muted November Sales Ahead Of Q1 Earnings
Costco's slowing November sales growth echoes a warning on changing spending habits from Target.
Five Below Stock Surges On Q3 Earnings Beat, Improving Sales Trends
"We're really off to a very solid start to the quarter. It's in line with our forecast, and we see no reason for that to stop," said CEO Joel Anderson.
Dollar General Stock Slumps As Rising Costs Clip Q3 Earnings, 2022 Outlook
"We believe the majority of these and other gross margin pressures are largely temporary, and we are confident in our plans to drive greater supply chain efficiencies moving forward,' said CEO Jeff Owen.